Prediction of maximal oxygen consumption by six minute walk testing in patients with congestive heart failure  by Goldsmith, Rochelle L. et al.
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The actual exercise duration, ETT vadablas, other clinical history or medical 
regimens were not predictive. Free of cardiac events were =J6% (C153-82) at 
5 yrs and 47=/= (C133-68) at 10 yrs. The survival rate was 98% ((310.89-1.0) 
at 5 yrs and 85% (CI 0.71-1.0) at 10 yrs. Conclusions: 1. SED alone does not 
constitute an adverse outcome. 2. In second opinion CAD patients managed 
with medical therapy and a short exercise duration, mortality is not predicted 
by ETT variables, but by type of angina and medical regimen. 
~ Dlpyridamole Induced ST-segment Depression 
Predicts Isehemla in Patients With Left 
Ventricular Hypertrophy by ECG 
Dennis A. Tighe, Barbara A. Faile, Said M. Zu'bl, James R. Cook. Baystate 
Medical Center, Springfi,}l~ MA 
ST-segment depression (STdpr) in the presence of LVH by ECG is an unre- 
liable marker of ischemia during exercise stress testing. Dipyridamole (DP) 
induced STdpr is a highly specific marker of ischemia, however its sig- 
nificance is unknown in patients (pts) with LVH by ECG. We studied 484 
consecutive pts undergoing DP pedusion imaging (0,57 mg/kg over 4 min 
with sestamibi injection at 8 rain) for development of > 1 mm horizontal 
or downsloping STdpr. An additional 1 mm STdpr was required if baseline 
STdpr was present. LVH was defined by standard ECG cdteda. Ischemia 
was defined as any new peffusion defect compared *q the resting scan. Pts 
with LBBB or ventricular paced rhythm (n = 31) were excluded. Four groups 
were identified: LVH with STdpr, LVH without STdpr, STdpr without LVH, no 
STdpr no LVH. Antianginal and digoxin use was similar among groups. STdpr 
occurred in 22/78 (28%) pts with LVH versus 351375 (9.3%) lots without LVH 
(p < 0.001). Ischemia occurred in 15/22 (68%) LVH pts with STdpr versus 
14/56 (25%) LVH pts without STdpr (p = 0.002). Ischemia frequency was sim- 
ilar in STdpr lots regardless of LVH by ECG (p = 0.28). DP infusion increased 
heart rate and rate-pressure product (RPP) and decreased blood pressure 
in each group. LVH lots with STdpr had higher esting and peak heart rates 
and RPP as compared to LVH pts without STdpr (all p < 0.04). No significant 
difference in resting and peak heart rate and RPP was present among STdpr 
pts with or without LVH. Chest pain occured with higher frequency in LVH 
pts with STdpr V s without STdpr (11122 vs 12/56; p < 0.02) but with similar 
frequency compared to STdpr pts without LVH. 
Conclusions: (1) DP induced STdpr is more frequent in pts with vs without 
LVH by ECG. (2) The frequency of ischemia and hemodynamic effects 
induced by DP are similar in STdpr pts independent of LVH by ECG. (3) DP 
induced STdpr in Lots with LVH by ECG is predictive of iechemia. 
~ Mechanism of Preserved Exercise in Capacity 
Patients With Reduced Left Ventricular Function 
Yoshlo Kobayashi, Yoichi Gore, Yoshiaki Okano, Yasunofi Nakayama, 
Toyohisa Miyashita, Toru Satoh, Hiroshi Takaki. National Cardiovascular 
Center, Osaka, Japan 
To elucidate the mechanism of preserved exercise capacity in patients with 
reduced left ventricular (LV) function, 71 patients with myocardial infarction 
underwent a symptom-limited irwasive cardiopulmonary exercise test with a 
cycle ergometer in a supine position. Patients were divided into two groups 
according to LV ejection fraction (EF) at rest; Group A (n = 20): EF > 40% (avr. 
56 4- 6%), Group B (n = 51): EF < 40% (avr. 31 ± 7%). Cardiac output and LV 
pressure were measured with a Swan-Ganz catheter and a tipped catheter, 
respectively, at rest and during exercise. LV stiffness index was calculated as 
(left vantflcular end-diastolic pressure - minimum prassure)/atroke volume 
index (St), 
CI SI ' HR a-vDO2 VO2 Stiffness 
AReal 4.1±0.8 56±9 754-11 3.24-0,8 3.64-0.8 0.2±0.1 
Peak 8.1±1.9 65±12 125±20 8.1:1:1,8 16.54-4.9 0,3:1:0.1 
BRest 3,7+0,8* 48±8 # 76±10 3.7±0.9 # 3,5±0,7 0.3±0.1 # 
Peak 6,7±1.5 # 534-10 # 128±18 9.0±1.5" 16,3±4,4 0,4±0.1 # 
Cl: cardiac index (I/minim 2), SI (ml/m2), HR: heart rate (bpm), a-vDO2: arterlovenous O~ 
d=fference (ml/dll, VO2:02 uptake (rnl/min/kg), Stiffness: LV stiffness index, Peak: peak 
exercise. *p < 0.05, #p < 0.01 vs. Group A. 
Patients with reduced EF showed not only reduced CI and SI but also 
impaired iastolic function both at rest and during exercise. However, peak 
VO2 was comparable to that of the patients with higher EF, because a-vDO2 
fully compensated the reduced CI. Conclusion: In patients with reduced LVEF, 
exercise capacity is preserved by a compensatory increase in a-vDO2. HR 
and LV diastolic function are not likely to play a compensatory role in this 
setting. 
~ Maximal Testing Early Myocardial Exercise After 
infarction - -  Better to Predict Cardiac Events? 
Miguel A. Pereira, Francisco Femandes, Adilia Repelo, Os6rio Ara0jo, 
Pedro Redrigues, Servi~o de Cardto/ogia, Hospital de S. Marcos, Braga, 
Portugal 
The aim of this prospective study was to evaluate if predischarga maximal 
exercise treadmill testing (ETT) after myocardial infarction (MI) is supedor to 
the classic low level (HR < 70% of age predicted) ETT, for risk stratification, 
We studied a group of 124 consecutive patients (P), 111 men and 13 
women, mean age 56.1 ± 9.7 years, addmitted with MI (52 infedor, 48 an- 
terior, 24 non-Q) who pedormed a predischarge (10.4 4- 2.3 days) symptom 
limited ETT, without antHschemi¢ medication, using a modified Bruce pro- 
tocol. There was no maj~or complicatlons. We have registered in all pattants 
some vadablas (exercise duration, symptoms, HR, systolic BP, double prod- 
uct, ST segment depression and arrhythmias) at HR == 73% and at peak 
exercise. Only 13 P had not achieved a HR > 700 of predicted. 23 P had 
positive (ST-segment depression with or without chest pain) ETT at HR < 
70% and 18 additional P had positive ETT at HR > 70%0, In the follow-up 
(mean 20.7 4- 5,2 months) 51 P suffered cardiac events (recurrent angina, 
reinfarctlon, cardiac death, PTCA, CABG). Of these 51 P only 18 had a 
positive test at low level but 32 P had positive test at peak exercise. 33 P 
with negative ETT at HR < 7(P/= had suffered events versus only 19 P with 
negative maximal ETT, 14 of the 18 P (78%) with positive ETT only after HR 
> 7(P/o (P with negative low level ETT) had cardiac events in the follow-up. 
Prediecharge ETT for detection cardiacs events in the follow.up: 
HR < 70°/0 Maximal 
Sensitivity 0,35 0,63 
Specificity 0.93 0.88 
Predictive Value (+) 0,78 0.78 
Predictive Value ( - )  0.67 0.77 
Conclusion: Prodischarge maximal E'Fr appears to be safe and better than 
low level ETT for risk stratification a~er MI. 
~ Relationship Between Resting Blood Pressure 
and Perception of Angina Pectorls During 
Exercise 
Rungrej Kdttayaphong, David S. Shape. University of North Carolina, 
Chapel Hill, NC 
Previous studies in animals and humans have shown decreased pain per- 
ception in hypertensives. To test the hypothesis that rssting blood pressure 
influences anginal pain perception during exercise, we reviewed 4723 exer- 
cise treadmill test results performed at UNC Hospitals dudng 1990-1994. All 
tests were interpreted by one cardiologist. 1144 tests were positive, defined 
as 1 mm horizontal or downsloping ST segment depression at 0.08 seconds 
after the J-point. Patients with conditions that affect anginal perception (di- 
abetes mellitus, post CABG), exercise protocol other than Bruce, who were 
taking antianginal medication or digoxin were excluded. Patients with rest- 
ing ECG abnormalities (LVH, LBBB, WPW), ECG changes with posture -r 
hyperventilation were also excluded. Two hundred thirty five patients wt,r= 
positive tests remained after exclusion. Hemodynamlc data were obtained at 
rest and during exercise (2 minutes into each stage). Angina was reported 
in 65 patients, Compared to patients with angina, patients without angina 
had a higher resting systolic (135 4- 1,6 vs 128 ± 2.2 mmHg, p ,, 0.02) and 
diastolic (83 ± 0.8 vs 80 + 1.3 mmHg, p -- 0.04) blood pressure without any 
differences in resting heart rate (79 ± 0.9 vs 78 ± 1.Sbpm, p = ns). "Rme 
to onset of 1 mm ST depression and double product at 1 mm ST depres- 
sion were the same for both groups. Fourteen out of 74 patients (19%) with 
resting SBP < 140 mmHg had angina dudng exercise whereas 51 out of 
161 (3L:~,,) patients with resting SBP _< 140 mmHg had angina (p = 0.04). 
In conclusion: patients with higher resting blood pressure have less frequent 
angina during exercise. Thus resting blood pressure appears to be related to 
pain perception in patients with CAD, 
~ Prediction of Maxima' Oxvn,m Consumption by 
Six Minute Walk Testing in'Patients With 
Congestive Heart Failure 
Rochelle L Goldsmith, James R Whelan, Alan D. Weinberg, Amy 
A, Whelan, Milton Packer, Keith D. Aarenson. Columbia, University NY, NY 
Maximal oxygen consumption (VO2max) is widely used for dsk stratification 
in CHF but is expensive and not widely available. The 6 minute walk test 
(6MW) provides an inexpensive and readily available measure of submaximal 
exercise capacity, and may be closely correlated to VO2max. Therefore, we 
measured 6MW and VO2max during treadmill exercise on CHF patients 
referred for functional assessment; data on 237 lOtS (190 men, 47 women; 
age 50.2 ± 11.4 years) who achieved R values > 1.1 were included in this 
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analysis. Unear regression models were developed to predict In(VO2max) 
from 6MW with and without 8SA, age, and sex. 
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Inclusion of BSA and age significantly improved the model (In[VO2max] 
in mYmin = 4.569 + 0.0026 (6MW) + 0.838 BSA - 0.0036 Age; r = 0,902). 
In conclusion, use of this regression model may, if validated, allow accurate 
prediction of VO2 max from 6MW. 
~ Arachldonic Ac id- Induced Dilation of  Eplcardlal 
coronary  Artery Is Maintained in Awake Dogs 
With Chronic Exerc ise Training Plus Rapid 
Cardiac Pacing 
Gang-Hua Yi, Daniel Burkhaff, Mathtas Knecht, Suili Pop,skis, 
Milton Packer, Jie Wang. Columbia Univ. College of P&S, New York, NY 
Previous studies has shown that arachidonie acid(AA)-induced dilation of 
epicardial coronary artery (CA) is attenuated but PGI2-induced dilation of CA 
is preserved in heart failure (CHF), suggesting that the attenuated response 
of AA is due to defective endothelial conversion of AA to prostacyclins. Since 
exercise training (EX) normalizes some aspects of endothelial function, the 
objective of this study was to determine whether EX improves AA-Inducad 
dilation of CA during development of CHR Dogs(n = 6) were chronically 
instrumented for measurements of left ventricular and aortic pressure, coro- 
nary blood flow and diameter of CA and for chronic cardiac pacing. Dogs 
were cardiac paced for 4 wks and treadmill EX (4.4 -;- 0.36 kin/hour) was 
performed on a treadmill 2 hours/day throughout this 4 wks. Changes in CA 
diameter induced by AA were examined before (Control) and after this 4 wk 
period (Pacing plus exercise). The results are as follows: 
Baseline Response ~ % & 
Centre! 
AA 250 #g/kg 3.50 ± 0.26 3.63 ± 0.25 0.14 ± 0.03" 4.15 ± 1.10" 
AA 500 pg/kg 3.50 ± 0.26 3.68 ± 0.26 0.18 ± 0.05* 5.23 ± 1.57 ° 
After 4 wk pacing plus exercise 
AA 250 #g/kg 3.81 ± 0.21 3.93 ± 0.20 0.13 ~ 0.02" ~..',7 ~- 0.74* 
AA 500 ~g/kg 3.79 ± 0.22 3.96 ± 0.22 0.17 ~ 0.02* 4.52 -..+. 0,76* 
values are CA diameter in ram. "p < 0.05 from baseline 
This contrasts with previous results showing that the response of CA 
diameter to AA is eliminated in dogs with the same pacing regimen but 
without exercise. Thus, EX training protected endotheliurrdprostaglandin- 
mediated dilation of CA dudng development of CHR This may indicate that 
the conversion of AA to prostacyclins was normalized by EX. 
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~ Natdu~et;~, Inhibit ~ndothelin-1 and Popl ldcs  
Anglotensln-l l  Mediated Human Coronary Smooth  
Muscle Cell Prol l ferat lon 
Chi-Ming Wet, John C. Bumett, Jr.. Mayo Clinic, Rochester, MN 
Atrial natrluretie pep"de (ANP), brain natriuretlc pap,de (BNP) and C-type 
natriuretie pep"de (CNP) are a family of structurally related paptldes that 
participate in the integrated control of renal and cardiovascular funotlon via 
activation of particulate guanylyl cyciase and generation of cGMP. While an 
antimitogenic action for the natriuretic pep"des have been investigated in 
non-human mammalian cells, the antiprellferatlve ncllon of the naMuretic 
peptides in human coronary vascular smooth muscle ceils (HCVSMC) pro- 
llferatlon remain undefined. Therefore, the current study was designed to 
investigate the inhibitory function of ANP, BNP and CNP upon endothelin- 
I (ET-1) and anglotensin II (All) mediated HCVSMC pmliteration. Cultured 
HCSMC were stimulated by ET-t (10 -7 M) and All (10 -7 M) with and without 
ANP.BNP and CNP (10 -~ M each) and thymidine incorporation determined. 
These studies were repeated with HS-142-1 (10 -s M), an antagonist of the 
na~urotie pep"de guanylyl cydase linked receptors. (cpnVwell) 
Control ET-1 ET-1 + HS All All + HS 
Baseline 190±24 1362±288§ 929-4-186§ 
ANP 420 ± 133" 630 ± 278 t 161 ± 33" 882 ± 251 ~" 
BNP 240±61" 766 -;- 2231' 156-I-26- 813±2381 
CNP 296±51" 1233 ±589t 153±30" 592± 200t 
§p < 0.05 vs control; *p < O.O5 vs baseline; tp < 0.05 va ET arid All. 
These data suggest: (1) ET-1 and All are potent stimulators for human 
coronary vascular smooth muscle cells proliferation. (2) ANP, BNP and CNP 
are potent inhibitors for ET and All media',ed human coronary smooth muscle 
cell proliferation. (3) These inhibitory actions of ANP, BNP and CNP are 
mediated by guanylyl cycl~..e linked natduretic peptide receptors 
~ Interact ion o f  Endothelin-1 With Vasodi lators:  
Effects on Myocardial  Contracti l i ty and Myocardial  
Energy Metabol ism 
Martin E. Bayer, G0nther $1esak, Silks Kazmaier, Stefan Nerz, Uwe Helber, 
Hans Martin Hoffmeister. Mad/ca/Hospital, Dept. ill, University of TObingen, 
Germany 
In contrast o in vitro experiments, which demonstrated a positive inotropy of 
endothalin-1 (ET-1), in viva studies could not detect such a positive inotropy. 
It was supposed that the direct positive inotropy of ET-1 is counterbalanced in 
viva by an indirect cardio-depreasant effect due to its vasoconstrictive effect 
with consequent myocardial ischemia. If this hypothesis is true the positive 
inoIropy of ET-1 Should be unmasked by coronary vasedilating drugs. 
We examined in open-chest rats whether adenosine (ADO: 2.0 mg,~g/min) 
or mcisidomine (MOL: 5.0 mg/kg) can unmask this positive inotropy of 1.0 
nmol/kg ET-1 i. v. by preventing myocardial ischemia. Besides measure- 
ments in the intact circulation isovelumic measurements (isovol. LVSP, iso- 
voL dP/dtmax) were performed for quantification of myocardial contraclJlity. 
Additionally myocardial high-energy phosphates were determined (energy 
charge : [ATP + 1/2AOPIAATP + ADP + AMP] as index of ischemia). 
ET-1 ADO ÷ ET-1 M'IL + ET-I NaCI 
Isevol. LVSP [%] 104±2 113±2" 108±2" 97±2 
IsevoL dP/dtmax [%] 98:1:3 120+3" 115±5" 100±2 
TPR ~a] 286±21 ° 236±27" 269 ±27* 96±3 
ATP ~moVgww] 3A±0.1" 3.8±0.1 4.3±0.3 4.1-;-0.1 
Energy charge [%1 73±3 ° 85±2 80±2 84±2 
Means :1: SEM; nemodynamics in% of pminfusion values, "p < 0.01. 
Conclusions: Adenosine and melsidomina antagonize the ET-induced 
vasoconstriction in pert and can unmask the positive inotropy of ET-1 by 
preventing ET-induced myocardial ischemia. 
~ Sustained Tissue Nitric Oxide Release Af ter  Local 
Delivery o f  a Novel Nitric Oxide Donor  
David S. Marks, Vincent J. Pomp"i, Myung H. Jecng, Whyte G. Owen, 
Zvonimir S. Katusic, David R. Holmes, Jr., Robert $. Schwartz. 
Cardiovascular Disease and Special Hematology, Mayo Clinic, Rochester, 
MN 
Nitric oxide (NO) is a potent vasodilator and platelet inhibitor. The tecal 
delivery of small-molecular weight NO-dehOrn has been associated with 
marked biologic elfects extending beyond the short holf-lite of these com- 
pounds. To examine the NO elaborated by vessels exposed to local de- 
livery of NO-donors, we administered a spontaneous NO-donating com- 
pound, Dansylpiperezine nonoate (GLO/NO) (1--2 raM) intraluminally to de- 
endothelialized porcine carotid arteries ex-vivo, rinsed the vessel free of the 
agent, and assayed for nitrite predu~on fluoromalrtcally two houm after local 
delivery. Nitrite in the supemalast after local delivery of GLO/NO was ele- 
vated (771.4-133 nM/gm tissue) compared to de-endothelielized control (438 
+ 68; p = 0.002) and to local delivery of the vehicle (385 ::t: 34; p = 0.008), 
GLO/NO treated vessels exhibited marked displaceabie NO elaboration after 
exposure to HgCI2, compared to vehicle (320.4-148 vs. 370.4- 69; p = 0.001) 
demonstrating substantial tissue thidl nitrcsation by this agent. 
Cone/us/on: Local administration of low molecular weight NO-denors re- 
sults in marked NO elaboration after treatment. These observations suggest 
tissue bound NO promotes the prolonged biologic effects after local delivery 
of NO-donors and suggests a potential therapy to mitigate adverse events 
after vascular injury. 
